Skip to main content

Table 1 Association between mRNA expression of PSF3 and clinicopathological characteristics in 137 patients with colorectal cancer

From: Partner of Sld five 3: a potential prognostic biomarker for colorectal cancer

Variables Total PSF3 expression P-value
Low level High level
No. of patients 137 66 71  
Age in years, mean × SD (range) 61.2 × 7.6 (37"86) 59.4 × 7.1 (37"81) 63.5 × 8.8 (42"86) 0.634
Gender, M/F 89/48 42/24 47/24 0.728
Tumor size     0.013*
<5 cm 105 55 50  
≥5 cm 32 11 21  
Depth of wall invasion     0.006*
Tis-T2 81 43 38  
T3-T4 56 23 33  
Lymph node metastasis     0.047*
Negative 76 39 37  
Positive 61 27 34  
Distant metastasis     0.125
No 118 58 60  
Yes 19 8 11  
TNM stage     0.008*
I/II/III/IV 46/54/22/15 28/26/8/4 18/28/14/11  
Differentiation     0.021*
Well/Moderate 94 52 42  
Poor 43 14 29  
Adjuvant chemotherapy     0.079
Yes 42 22 20  
No 95 44 51  
Five-year survival     0.002*
Yes 58 35 23  
No 79 31 48  
  1. M/F Male/Female, PSF3 partner of Sld five 3, SD standard deviation.
  2. *Significant P-value.